Deep Health AI India FY26 Performance Review

Standalone Profit: Rs 1.29 crore (FY26) versus Rs 0.86 crore (FY25).
Exceptional Loss: Rs 5.77 crore recognized due to a failed business acquisition.

Reader Takeaway: Revenue growth provides operational stability, but the Rs 5.77 crore exceptional loss from the failed acquisition creates overhang.

What just happened

Deep Health AI India Limited released its 32nd Annual Report for FY 2025-26. The company successfully completed a rights issue of 9.61 crore shares at Rs 4.16 per share, mobilizing Rs 39.97 crore. Simultaneously, the firm reported a rise in total income to Rs 8.49 crore from Rs 2.00 crore in the previous year. However, the company has hit a major hurdle regarding its proposed acquisition of Oasis Ceramics Pvt Ltd.

Why this matters

The financial gain from core operations is currently being weighed against a substantial exceptional loss. The company failed to complete the Oasis Ceramics buyout after paying an initial Rs 2.55 crore (EMD plus consideration). A bank guarantee worth Rs 3.21 crore was invoked by the Resolution Professional, leading to a total charge of Rs 5.77 crore on the company's books. This situation is now under NCLT proceedings.

Risks to watch

Investors must monitor the legal outcome at the NCLT, as the stalled acquisition has already caused a significant capital impairment. Additionally, the utilization of the remaining rights issue proceeds—of which Rs 37.47 crore was temporarily deployed in investments—remains a critical point for shareholder oversight.

What to track next

The 32nd Annual General Meeting is scheduled for September 30, 2026. Key items to track include the formal appointment of Vimal C. Surana & Co. as new statutory auditors and any further updates on the recovery or final status of the Oasis Ceramics transaction.